In conclusion, the present study developed a safe, stable, and well immunogenic attenuated S. agalactiae strain YM001, which induced good immune-protection in tilapia via oral immunization. Therefore, YM001 can be used as a novel safe and efficacious vaccine to protect tilapia against S. agalactiae infections